MarketPeel
Insider Trading Intelligence
PM

Philippe Menu

SOPH
CHIEF MEDICAL OFFICER · SOPHIA GENETICS SA · CIK 0002014308
FILING MIX · LIFETIME18%/82%
BUYS
4
SELLS
18
TOTAL VALUE
$293.8K
COMPANIES
1
ACTIVE SINCE
Mar 2026
HOLDINGS NOW
228,387
AVG SELL PX
$5.00
TRADE KIND
SHOWING 22 / 22
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
12 backtested trades · 8 horizons · 39 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Philippe Menu, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d12+25.00%+3.63%+2.52%+1.22%+1.84%
14d12+8.33%+2.65%+3.99%-1.58%-1.88%
30d12+33.33%+2.08%+7.79%-4.74%-5.02%
60d12+20.00%+4.52%+8.15%-3.53%-4.45%
90d12(3 pending)+0.00%+11.83%+11.04%+0.79%+5.04%
180d12(12 pending)
1y12(12 pending)
2y12(12 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SOPH · 228,387 shares · as of Jul 13, 2026
071,638143,276214,914286,552SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2026
2026
2026
FLOW · 4 buys / 18 sellsCOVERAGE · 3 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
5,000$5.70$28.5K228,387Jul 13, 2026Jul 14, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
7,393$5.16$38.2K233,387Jul 6, 2026Jul 7, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
5,000$5.50$27.5K240,780Jun 25, 2026Jun 26, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
5,000$4.95$24.8K245,780Jun 12, 2026Jun 15, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
5,000$4.95$24.8K250,780May 26, 2026Jun 1, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
608$4.61$2.8K255,780May 19, 2026May 20, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
5,000$4.67$23.3K256,388May 12, 2026May 13, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
5,000$4.82$24.1K261,388Apr 27, 2026Apr 28, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
608$5.20$3.2K266,388Apr 20, 2026Apr 21, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
1,600$4.96$7.9K266,996Apr 14, 2026Apr 16, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
3,400$4.76$16.2K268,596Apr 13, 2026Apr 14, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
1,000$4.76$4.8K271,996Apr 13, 2026Apr 14, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
3,725$4.68$17.4K272,996Apr 10, 2026Apr 14, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
1,931$4.74$9.2K276,721Apr 9, 2026Apr 10, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
2,800$4.84$13.5K278,652Apr 8, 2026Apr 10, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
2,400$4.87$11.7K281,452Apr 7, 2026Apr 8, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
2,700$4.85$13.1K283,852Apr 6, 2026Apr 8, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
112,936112,936Apr 2, 2026Apr 3, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
164,671164,671Apr 2, 2026Apr 3, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
164,671164,671Apr 2, 2026Apr 8, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
112,936286,552Apr 2, 2026Apr 8, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
608$4.79$2.9K173,616Mar 19, 2026Mar 20, 2026View →
Other insiders · SOPH
Loading peer insiders…
About this filer
CIK 0002014308
ROLE
Chief Medical Officer
PRIMARY
SOPH
COMPANIES
1
ACTIVE SINCE
Mar 2026
MARKETPEEL · /INSIDER/0002014308DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback